Xbiotech - Articles and news items

Xilonix demonstrates significant clinical response in colorectal cancer study

Industry news / 4 July 2016 / Victoria White, Digital Content Producer

XBiotech’s Xilonix is the first monoclonal antibody immunotherapy to specifically target and neutralise interleukin-1 alpha (IL-1α)…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+